May 7th 2025
This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Eight Pharma Companies Join Non-Profit Association Aimed at Achieving Net Zero Emissions
June 3rd 2021Eight companies representing the pharmaceutical supply chain have joined a newly founded non-profit membership association, Alliance to Zero, aimed at facilitating the transition of the pharma sector to comply with net-zero emissions.